Gemcitabine metabolic pathway genetic polymorphisms and response in non-small cell lung cancer patients

BACKGROUND AND OBJECTIVE: Gemcitabine is widely used to treat non-small cell lung cancer (NSCLC). To assess the pharmacogenomic effects of the entire gemcitabine metabolic pathway, we genotyped SNPs within the 17 pathway genes using DNA samples from NSCLC patients treated with gemcitabine to determi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Li, Liang, Schaid, Daniel J., Fridley, Brooke L., Kalari, Krishna R., Jenkins, Gregory D., Abo, Ryan P., Batzler, Anthony, Moon, Irene, Pelleymounter, Linda, Eckloff, Bruce W., Wieben, Eric D., Sun, Zhifu, Yang, Ping, Wang, Liewei
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3259218/
https://ncbi.nlm.nih.gov/pubmed/22173087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e32834dd7e2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg